Cargando…
Intranasal Xylitol for the Treatment of COVID-19 in the Outpatient Setting: A Pilot Study
It is well known that acute COVID-19 infection can present with a variety of symptoms, including fever, cough, rhinitis, loss of taste, and the cardinal sign of loss of smell (anosmia). Recently, nasal irrigations with saline and other agents have shown promise for the treatment of COVID-19. Xylitol...
Autores principales: | Soler, Evangelina, de Mendoza, Amanda, Cuello, Víctor I, Silva-Vetri, Maria G, Núñez, Zoilangel H, Ortega, Ramsés G, Rizvi, Syed A, Sanchez-Gonzalez, Marcos, Ferrer, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395150/ https://www.ncbi.nlm.nih.gov/pubmed/36039203 http://dx.doi.org/10.7759/cureus.27182 |
Ejemplares similares
-
A Randomized Controlled Pilot Trial to Test the Efficacy of Intranasal Chlorpheniramine Maleate With Xylitol for the Treatment of Allergic Rhinitis
por: Sanchez-Gonzalez, Marcos, et al.
Publicado: (2021) -
Microbiomics of irrigation with xylitol or Lactococcus lactis in chronic rhinosinusitis
por: Lambert, Paul A., et al.
Publicado: (2021) -
A New Grand Challenge in Rhinology: An Intranasal COVID Vaccine
por: Scadding, Glenis Kathleen
Publicado: (2022) -
In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2
por: Westover, Jonna B, et al.
Publicado: (2020) -
Response to intranasal Lactococcus lactis W136 probiotic supplementation in refractory CRS is associated with modulation of non-type 2 inflammation and epithelial regeneration
por: Al-Romaih, Saud, et al.
Publicado: (2023)